Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 1
1988 3
1989 2
1990 2
1991 1
1992 2
1993 2
1994 7
1996 4
1997 5
1998 3
1999 1
2000 5
2001 3
2002 2
2003 2
2004 5
2005 4
2006 5
2007 9
2008 8
2009 5
2010 11
2011 1
2012 4
2013 6
2014 2
2015 4
2016 7
2017 2
2018 7
2019 9
2020 7
2021 4
2022 5
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Results by year

Filters applied: . Clear all
Page 1
Prophylaxis and treatment of cancer-related dyspnea with pharmacologic agents: A systematic review and network meta-analysis.
Chow R, Hui D, Caini S, Simone CB 2nd, Prsic E, Boldt G, Lock M. Chow R, et al. Palliat Support Care. 2022 Oct;20(5):744-751. doi: 10.1017/S1478951521001656. Palliat Support Care. 2022. PMID: 36111729 Review.
RESULTS: Twelve studies were included in this review; six reported on prophylaxis of exertional dyspnea, five on treatment of everyday dyspnea, and one on treatment of episodic dyspnea. Morphine sulfate was better at controlling everyday dyspnea …
RESULTS: Twelve studies were included in this review; six reported on prophylaxis of exertional dyspnea, five on treatment of everyda …
Opioids for the management of dyspnea in cancer patients: a systematic review and meta-analysis.
Takagi Y, Sato J, Yamamoto Y, Matsunuma R, Watanabe H, Mori M, Hasegawa T, Matsuda Y, Kako J, Kasahara Y, Goya S, Kohara H, Nakayama T, Yamaguchi T. Takagi Y, et al. Int J Clin Oncol. 2023 Aug;28(8):999-1010. doi: 10.1007/s10147-023-02362-6. Epub 2023 Jun 20. Int J Clin Oncol. 2023. PMID: 37338727 Free PMC article. Review.
Dyspnea is a prevalent symptom that significantly reduces quality of life of cancer patients. ...Systemic administration of opioids is more effective than placebo in relieving dyspnea in cancer patients. Robust evidence on the efficacy and safety of opioids on dy …
Dyspnea is a prevalent symptom that significantly reduces quality of life of cancer patients. ...Systemic administration of opioids i …
Dyspnea in Cancer Patients: A Well-Known and Neglected Symptom.
Meriggi F. Meriggi F. Rev Recent Clin Trials. 2018;13(2):84-88. doi: 10.2174/1574887113666180326112116. Rev Recent Clin Trials. 2018. PMID: 29577864 Review.
Opioids such as morphine remain the cornerstone of treating dyspnea. CONCLUSION: Dyspnea is a complex, multidimensional symptom that results from an interaction between factors and their causes, perception and expression. ...Dyspnea remains a well-know …
Opioids such as morphine remain the cornerstone of treating dyspnea. CONCLUSION: Dyspnea is a complex, multidimensional …
Effects of Oral Morphine on Dyspnea in Patients with Cancer: Response Rate, Predictive Factors, and Clinically Meaningful Change (CJLSG1101).
Takahashi K, Kondo M, Ando M, Shiraki A, Nakashima H, Wakayama H, Kataoka K, Yamamoto M, Sugino Y, Nishikawa M, Imaizumi K, Kojima E, Sumida A, Takeyama Y, Saito H, Hasegawa Y. Takahashi K, et al. Oncologist. 2019 Jul;24(7):e583-e589. doi: 10.1634/theoncologist.2018-0468. Epub 2019 Jan 18. Oncologist. 2019. PMID: 30659079 Free PMC article.
BACKGROUND: Although the efficacy of parenteral morphine for alleviating dyspnea has been previously demonstrated in several studies, little is known regarding the efficacy of oral morphine for dyspnea among patients with cancer, including its response …
BACKGROUND: Although the efficacy of parenteral morphine for alleviating dyspnea has been previously demonstrated in several s …
Systemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational Study.
Yamaguchi T, Matsunuma R, Matsuda Y, Tasaki J, Ikari T, Miwa S, Aiki S, Takagi Y, Kiuchi D, Suzuki K, Oyamada S, Ariyoshi K, Kihara K, Mori M. Yamaguchi T, et al. J Pain Symptom Manage. 2023 May;65(5):400-408. doi: 10.1016/j.jpainsymman.2022.12.146. Epub 2023 Jan 11. J Pain Symptom Manage. 2023. PMID: 36641006
We consecutively enrolled adult cancer patients starting regular opioids (morphine, oxycodone, hydromorphone, or fentanyl) for dyspnea from 12 palliative care services across Japan. ...CONCLUSION: Regular systemic opioids were effective for dyspnea in real-wo …
We consecutively enrolled adult cancer patients starting regular opioids (morphine, oxycodone, hydromorphone, or fentanyl) for dys …
Symptoms of and Palliative Treatment for Unresectable Skin Cancer.
Goto H, Kiyohara Y, Shindo M, Yamamoto O. Goto H, et al. Curr Treat Options Oncol. 2019 Mar 27;20(4):34. doi: 10.1007/s11864-019-0626-5. Curr Treat Options Oncol. 2019. PMID: 30919223 Review.
For pain due to bone metastasis, pharmacotherapy with opioid and/or non-opioid agents is the most basic treatment, and radiation and bisphosphonate therapies are other options. For dyspnea, which is an intractable and uncomfortable symptom, morphine and oxygen play …
For pain due to bone metastasis, pharmacotherapy with opioid and/or non-opioid agents is the most basic treatment, and radiation and bisphos …
Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases.
Gamborg H, Riis J, Christrup L, Krantz T. Gamborg H, et al. J Opioid Manag. 2013 Jul-Aug;9(4):269-74. doi: 10.5055/jom.2013.0168. J Opioid Manag. 2013. PMID: 24353020 Clinical Trial.
BACKGROUND: Dyspnea is considered as one of the most frequent and distressing symptoms in patients with advanced cancer, and systemic administration of morphine has been reported to have beneficial effect on this complaint. AIM AND DESIGN: The effect of red morph …
BACKGROUND: Dyspnea is considered as one of the most frequent and distressing symptoms in patients with advanced cancer, and systemic …
Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults.
Simon ST, Higginson IJ, Booth S, Harding R, Weingärtner V, Bausewein C. Simon ST, et al. Cochrane Database Syst Rev. 2016 Oct 20;10(10):CD007354. doi: 10.1002/14651858.CD007354.pub3. Cochrane Database Syst Rev. 2016. PMID: 27764523 Free PMC article. Review.
BACKGROUND: This is an updated version of the original Cochrane review published in Issue 1, 2010, on 'Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults'. Breathlessness is one of the most common symptoms exp …
BACKGROUND: This is an updated version of the original Cochrane review published in Issue 1, 2010, on 'Benzodiazepines for the relief of bre …
Do Types of Opioids Matter for Terminal Cancer Dyspnea? A Preliminary Multicenter Cohort Study.
Mori M, Yamaguchi T, Suzuki K, Matsuda Y, Matsunuma R, Watanabe H, Ikari T, Matsumoto Y, Imai K, Yokomichi N, Miwa S, Yamauchi T, Okamoto S, Inoue S, Inoue A, Hui D, Morita T, Satomi E; Japanese Dyspnea Relief Investigators. Mori M, et al. J Pain Symptom Manage. 2023 Aug;66(2):e177-e184. doi: 10.1016/j.jpainsymman.2023.04.009. Epub 2023 Apr 18. J Pain Symptom Manage. 2023. PMID: 37080479
While physicians frequently use parenteral opioids other than morphine for terminal dyspnea, little is known about their effects in cancer patients. OBJECTIVES: To explore the effectiveness and safety of parenteral morphine, oxycodone, and hydromorphone for c …
While physicians frequently use parenteral opioids other than morphine for terminal dyspnea, little is known about their effec …
145 results